| Literature DB >> 28416701 |
Georgia Kouroupi1, Era Taoufik1, Ioannis S Vlachos2, Konstantinos Tsioras1, Nasia Antoniou1, Florentia Papastefanaki1, Dafni Chroni-Tzartou1,3, Wolfgang Wrasidlo4, Delphine Bohl5, Dimitris Stellas6, Panagiotis K Politis7, Kostas Vekrellis8, Dimitra Papadimitriou9, Leonidas Stefanis8,10, Piotr Bregestovski11, Artemis G Hatzigeorgiou2, Eliezer Masliah4, Rebecca Matsas12.
Abstract
α-Synuclein (αSyn) is the major gene linked to sporadic Parkinson's disease (PD), whereas the G209A (p.A53T) αSyn mutation causes a familial form of PD characterized by early onset and a generally severe phenotype, including nonmotor manifestations. Here we generated de novo induced pluripotent stem cells (iPSCs) from patients harboring the p.A53T mutation and developed a robust model that captures PD pathogenic processes under basal conditions. iPSC-derived mutant neurons displayed novel disease-relevant phenotypes, including protein aggregation, compromised neuritic outgrowth, and contorted or fragmented axons with swollen varicosities containing αSyn and Tau. The identified neuropathological features closely resembled those in brains of p.A53T patients. Small molecules targeting αSyn reverted the degenerative phenotype under both basal and induced stress conditions, indicating a treatment strategy for PD and other synucleinopathies. Furthermore, mutant neurons showed disrupted synaptic connectivity and widespread transcriptional alterations in genes involved in synaptic signaling, a number of which have been previously linked to mental disorders, raising intriguing implications for potentially converging disease mechanisms.Entities:
Keywords: Parkinson’s disease; axonal degeneration; dystrophic neurites; small molecules; α-synuclein
Mesh:
Substances:
Year: 2017 PMID: 28416701 PMCID: PMC5422768 DOI: 10.1073/pnas.1617259114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205